• WIZ.AI

  Participated · Equity · Jun 2022

  WIZ.AI develops enterprise-grade voice agents that leverage large language models to handle customer interactions across multiple channels with natural, locally accented speech. Its platform emphasizes strong security and elastic scalability so large organizations can rapidly adjust usage as demand shifts. The company is now accelerating work on an Artificial General Intelligence (AGI) platform and building comprehensive AI Partner Solutions tailored to Southeast Asian markets. Fresh capital will also support strategic expansion into additional emerging markets. By refining models to understand complex local dialects and cultures, WIZ.AI aims to set a new standard for enterprise customer communication. The startup has attracted backing from leading regional and global investors, underscoring confidence in its technology and market position. Its most recent Series B round brought in more than US$10 million to fund these growth initiatives.

• Flore by Sun Genomics

  Participated · Series A · Sep 2020

  Sun Genomics is a San Diego-based direct-to-consumer custom probiotics and gut health company founded in 2016 and led by CEO and founder Sunny Jain. Its flagship product, Floré, combines a microbiome test and personalized probiotic formulation using whole-genome sequencing to tailor products to individual gut profiles. The company expanded its line with Floré Defense in July 2020, an all-natural formula aimed at immunity and respiratory health. Sun Genomics intends to use new funding to grow in the custom probiotics market, scale delivery across the U.S., enter international markets, and propel publication of studies with academic institutions. The company also announced the addition of Dr. Jack Gilbert as medical and scientific advisor and Mayank Goel as vice president of growth to support research and commercialization efforts. Sun Genomics' core product, Floré, is a personalized probiotic service that uses DNA sequencing and micro-manufacturing to produce a customer-specific 90-day supply of probiotics. Customers send a micro-stool sample via a kit, receive a full microbiome (DigestiveDNA) analysis, and are shipped a tailored formula. The end-to-end process takes six weeks and costs $300 per 90-day supply; the company says a partnership with Illumina will enable delivery in two weeks by late 2020. Floré is available now on the company website, and Sun Genomics is in discussions with national retailers to expand distribution in 2020. The company highlighted industry awards (NEXTY Best Digestive Health Product and Food Funded Most Innovative Product) and user testimonials as part of its market positioning, and in 2019 closed seed funding to accelerate reach.

No current team members are available.